+
+

Related Products

  • SciSure
    295 Ratings
    Visit Website
  • RegDesk
    16 Ratings
    Visit Website
  • QBench
    134 Ratings
    Visit Website
  • Lockbox LIMS
    68 Ratings
    Visit Website
  • SAP S/4HANA Cloud Public Edition
    3,466 Ratings
    Visit Website
  • Qualio
    823 Ratings
    Visit Website
  • Digital WarRoom
    55 Ratings
    Visit Website
  • FrameworkLTC
    47 Ratings
    Visit Website
  • JDisc Discovery
    27 Ratings
    Visit Website
  • AthenaHQ
    18 Ratings
    Visit Website

About

BenevolentAI is an AI-enabled drug discovery platform and scientific technology company that unites advanced artificial intelligence, machine learning, and domain-specific science to accelerate the discovery, design, and development of new medicines for complex diseases by making sense of vast, diverse biomedical data and generating actionable scientific insights faster than traditional methods. Its proprietary Benevolent Platform ingests and harmonizes structured and unstructured biomedical information, including literature, genomics, clinical information, and multi-omics data, into a comprehensive knowledge graph, enabling scientists to reason across biological systems, generate hypotheses, predict novel drug targets, and design candidate molecules with higher confidence and lower failure rates.

About

Recursion is a TechBio company focused on transforming drug discovery by combining biology, data, and artificial intelligence. Founded over a decade ago, the company pioneered the use of large-scale cellular imaging to train AI models that decode the biological drivers of disease. Recursion’s mission is to deliver better medicines through novel insights and precision design, reducing the high failure rates of traditional drug development. Its proprietary Recursion OS platform integrates massive biological datasets with machine learning to accelerate discovery from target identification to clinical development. The company has built an advanced pipeline of potential first-in-class and best-in-class therapies targeting aggressive cancers and rare diseases. Automated wet labs and robotics enable millions of experiments per week, feeding continuous learning into its AI models.

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Platforms Supported

Windows
Mac
Linux
Cloud
On-Premises
iPhone
iPad
Android
Chromebook

Audience

Researchers, biopharma teams, and drug discovery professionals requiring a solution to uncover biological insights, identify therapeutic targets, and accelerate the development of new medicines

Audience

Recursion is ideal for researchers, pharmaceutical partners, investors, and healthcare stakeholders interested in AI-driven drug discovery and next-generation therapeutic development

Support

Phone Support
24/7 Live Support
Online

Support

Phone Support
24/7 Live Support
Online

API

Offers API

API

Offers API

Screenshots and Videos

Screenshots and Videos

Pricing

No information available.
Free Version
Free Trial

Pricing

No information available.
Free Version
Free Trial

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Reviews/Ratings

Overall 0.0 / 5
ease 0.0 / 5
features 0.0 / 5
design 0.0 / 5
support 0.0 / 5

This software hasn't been reviewed yet. Be the first to provide a review:

Review this Software

Training

Documentation
Webinars
Live Online
In Person

Training

Documentation
Webinars
Live Online
In Person

Company Information

BenevolentAI
Founded: 2013
Luxembourg
www.benevolent.com

Company Information

Recursion
United States
www.recursion.com

Alternatives

Alternatives

Scitara DLX

Scitara DLX

Scitara
Evo 2

Evo 2

Arc Institute

Categories

Categories

Integrations

No info available.

Integrations

No info available.
Claim BenevolentAI and update features and information
Claim BenevolentAI and update features and information
Claim Recursion and update features and information
Claim Recursion and update features and information